Arsiner Burcoglu-Oral, M.D. Joins The Oncology Institute of Hope and Innovation

Wednesday, February 27, 2019 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

The Oncology Institute of Hope and Innovation welcomes Arsiner Burcoglu-Oral, M.D., to their team of specialists.

CERRITOS, Calif., Feb. 26, 2019 /PRNewswire-PRWeb/ -- Dr. Oral received both her undergraduate and medical degree from

the Hacettepe University School of Medicine in Ankara, Turkey. She completed her residency at the Western PA / Allegheny Medical Center where she finished as a chief resident.

Dr. Oral has also held several academic appointments. She was an assistant professor and Medical Director of the HLA-Platelet Program, CD 34 Laboratory, Aphaeresis Department and Industry Trials at the University of Pittsburgh. She also taught at the National Institute of Health, University of Virginia, and Pittsburgh Cancer Institute.

Dr. Burcoglu-Oral believes that in order to relate to her patients she must be able to give them the proper knowledge. Knowing what the disease is, the treatment plan and implementing the standard of care. "I want to be able to give my patients confidence without compromising their quality of life. Knowledge is the best way to minimize their overwhelming isolation within the context of positioning them into the universality of objective medicine."

 

SOURCE The Oncology Institute of Hope and Innovation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store